Form 4 for VYGR Voyager Therapeutics, Inc.

Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-13 · accession 0001104659-22-005020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-01-18	2022-01-13	VYGR	Higgins Michael J	CEO, Interim Pres, Dir	A - Grant	$0.00	+45.2K	45.2K	New	$0
D	2022-01-18	2022-01-13	VYGR	Higgins Michael J	CEO, Interim Pres, Dir	A - Grant	$0.00	+161.0K	161.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-13	A	A	45,205	$0.00	45,205	D	—	—	(F1) Consists of shares of common stock issuable under an aggregate of 45,205 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, January 13, 2022. 100% of the shares of common stock underlying the RSU award vest on the six-month anniversary of such vesting commencement date, subject to the Reporting Person's continued service as a director, officer, or otherwise.
2	Derivative	Stock Option (Right to Buy)	2022-01-13	A	A	161,000	$0.00	161,000	D	$2.85 · — to 2032-01-13	161,000 Common Stock	(F2) This stock option was issued pursuant to the Plan. 1/5th of the shares of common stock underlying the option vest on each of February 12, 2022, March 12, 2022, April 12, 2022, May 12, 2022 and June 2, 2022, subject to the Reporting Person's continued service as an interim executive officer.